New Product Newswire
FDA Approves Imuldosa, Biosimilar to Stelara
The approval is supported by results from phase 3 multi-regional clinical trials conducted in patients with plaque psoriasis.
Episode 8: Stay in Sync with Innovations in Medication Decision Support
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
FDA Roundup: Biosimilar Approval, Hereditary Angioedema Treatment Receives Orphan Drug Designation
Check out important updates from the FDA for the week of September 30.
FDA Roundup: Agency Highlights from September 2024
Check out these important FDA updates from the month of September 2024.
FDA Approves Dupixent as First Biologic Treatment for COPD
Dupixent is a fully human monoclonal antibody that inhibits the signaling of the IL4 and IL13 pathways.
Schizophrenia Drug Approved by FDA Represents First New Treatment Option in Decades
The approval of xanomeline and trospium chloride (Cobenfy) from Bristol Myers Squibb represents a “transformative moment in the treatment of schizophrenia.”
